Home | Accelerate@Babraham | Meet the experts | Khatereh Ahmadi

Khatereh Ahmadi

Executive Director in BD&L, MSD/Merck

Khatereh Ahmadi has worked in the biotech/pharma industry for 15 years. Previous to her current role at MSD/Merck as Executive Director in BD&L in the oncology field, she was a co-founder and CEO of reViral Ltd, leading a Series A round of $21M with EdRIP and Orbimed. She played a significant role in the spin out of Piramed Ltd, and subsequently became head of business development culminating in a significant deal with Genentech and acquisition of Piramed by Roche in 2008. She has consulted for a number of EU and US companies in the oncology field. She obtained a PhD in biochemistry from King’s College London and held a post-doctoral position at the Ludwig Institute for Cancer Research in London working in the PI 3-kinase field. Dr. Ahmadi was awarded her MBA from Henley Management College.

Contact us


(+44) 1223 496 000

Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom

Press Enquiries

01223 813 557

Subscribe to our mailing list

Please enter your first name
Please enter your surname
Please enter your email address
; ;